- Home
- SILC vs ICUCW Comparison
SILC vs ICUCW Comparison
Compare SILC & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILC
- ICUCW
- Stock Information
- Founded
- SILC 1987
- ICUCW N/A
- Country
- SILC Israel
- ICUCW United States
- Employees
- SILC N/A
- ICUCW 12
- Industry
- SILC Computer Manufacturing
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- SILC Technology
- ICUCW Health Care
- Exchange
- SILC Nasdaq
- ICUCW Nasdaq
- Market Cap
- SILC 92.3M
- ICUCW N/A
- IPO Year
- SILC 1994
- ICUCW 2021
- Fundamental
- Price
- SILC $15.59
- ICUCW $0.02
- Analyst Decision
- SILC Hold
- ICUCW
- Analyst Count
- SILC 1
- ICUCW 0
- Target Price
- SILC N/A
- ICUCW N/A
- AVG Volume (30 Days)
- SILC 48.1K
- ICUCW N/A
- Earning Date
- SILC 01-30-2025
- ICUCW N/A
- Dividend Yield
- SILC N/A
- ICUCW N/A
- EPS Growth
- SILC N/A
- ICUCW N/A
- EPS
- SILC N/A
- ICUCW N/A
- Revenue
- SILC $62,386,000.00
- ICUCW N/A
- Revenue This Year
- SILC N/A
- ICUCW N/A
- Revenue Next Year
- SILC $4.15
- ICUCW N/A
- P/E Ratio
- SILC N/A
- ICUCW N/A
- Revenue Growth
- SILC N/A
- ICUCW N/A
- 52 Week Low
- SILC $11.35
- ICUCW N/A
- 52 Week High
- SILC $19.04
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- SILC 59.72
- ICUCW N/A
- Support Level
- SILC $15.03
- ICUCW N/A
- Resistance Level
- SILC $17.30
- ICUCW N/A
- Average True Range (ATR)
- SILC 0.87
- ICUCW 0.00
- MACD
- SILC 0.10
- ICUCW 0.00
- Stochastic Oscillator
- SILC 62.15
- ICUCW 0.00
About SILC Silicom Ltd
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters; Edge Networking Solutions; FPGA Based Cards; x86 Open Appliances Bypass Switches and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.